The University of Southampton

Bioprinting of hair follicles- Is this the solution to hair loss?

Imagine a world where baldness and hair loss is no longer a source of insecurity; a world where those suffering from these can regain their confidence and self-esteem. 

Hair bioprinting isn’t just about aesthetics. It holds promise for treating various hair and scalp-related conditions, such as alopecia, a condition that affects millions worldwide. By harnessing the regenerative potential of cells, this technology may offer hope to those who have been struggling with hair loss for years.

Figure 1: Graphical abstract from Ayaka Nanmo’s study (https://doi.org/10.1016/j.actbio.2022.06.021)

In one specific study, the replication of in-vivo tissue configurations and microenvironments like hair follicle germs has been studied to prepare tissue grafts for hair regenerative medicine. This study suggests an approach for the scalable and automated preparation of highly hair-inductive tissue grafts using a bioprinter.

Figure 2: Graphical description of the process of bioprinting of hair microgels (HMGs) and guide-inserted HMGs (gHMGs).

Hair follicle morphogenesis initiates with the formation of a primordium composed of mesenchymal and epithelial cells, instigating tissue development. Distinguished from other organs, the hair follicle generates the hair follicle germ (HFG) at regular intervals postnatally, perpetually renewing throughout life. In the pursuit of advancing hair regenerative medicine, diverse methodologies have been devised for engineering HFG-like grafts, with one of the most sophisticated methods being the use of bioengineered HFGs. This method entails the compartmentalization of mesenchymal and epithelial cell aggregates to elicit interactions, thereby fostering efficient hair follicle regeneration and establishment of connections with host arrector pili, nerve fibers, and recurring hair cycles upon transplantation. However, this approach may be challenging to scale up to the human setting due to laborious manual preparation steps, especially considering the need for thousands of tissue grafts for a single patient. So, there exists a need for a scalable, highly hair-inductive, and preferably automated approach for HFG preparation.

Exploration into scalable methodologies for preparing mesenchymal and epithelial aggregates has predominantly centered around the concept of cell self-organization. Among these approaches, one notable method entails the seeding of a blend of these cellular components onto a flat substrate. This process gives rise to the formation of spherical aggregates characterized by a mesenchymal core enveloped by an epithelial shell. However, while promising, this technique has encountered a notable challenge: the wide distribution of spheroid sizes. This variability in size could potentially lead to unpredictable outcomes in terms of hair-inducing functionalities. It’s been observed that the size of these spheroids correlates with the number of hairs generated, hinting at the intricacies of the relationship between structure and function in tissue engineering endeavors.

Pairs of collagen droplets housing mouse embryonic mesenchymal and epithelial cells were meticulously positioned adjacent to each other and sequentially underwent gelation. In the subsequent suspension culture, the microgel beads spontaneously contracted, thereby enriching the density of collagen and cells after three days of culture. The contracted microgel beads were termed HMGs or hair microgels. To evaluate their hair-inducing potential, they were transplanted into the dorsal skin of nude mice. gHMGs were fabricated in the same manner, but by placing pairs of collagen droplets on aligned surgical suture guides. The effects of the guides were examined after transplantation into the nude mice.

Fast forward to 2017, where the beauty giant L’Oréal made headlines by partnering with the biotech firm Poietis, renowned for its expertise in crafting 3D models of human tissues, to embark on the groundbreaking endeavor of bioprinting hair follicles. Hair bioprinting is a prime example of interdisciplinary collaboration. It brings together experts from fields like biology, engineering, and medicine, all working together to unlock the potential of this cutting-edge technology.

While the prospect of bioprinting hair follicles holds great promise, further refinement of the process is required and extensive research is needed to ensure its safety and long-term effectiveness. On one hand, the idea of being able to customize hair growth feels like a step towards empowerment, a chance to redefine our appearance according to our own desires. But on the other hand, it raises questions regarding the accessibility and affordability of this technology to a broader demographic that must be addressed, underscoring the importance of making cutting-edge advancements in regenerative medicine inclusive and sustainable. Who will have access to this technology? Will it be reserved for the privileged few, widening the gap between those with the finance and those who don’t? Or will it be made accessible to all, ensuring that advancements in science benefit everyone? It’s not just about innovation; it’s about equity and justice. As we navigate the uncharted territory of bioprinting, we must ensure that it’s not just a luxury for the elite, but a tool for empowerment and inclusivity. Only then can we truly harness its transformative potential for the betterment of all.

Tissue Engineering- Is it ethical?

In the realm of medical science, tissue engineering stands as a beacon of hope, offering revolutionary solutions to some of the most challenging health problems. It’s a field where biology meets engineering, aiming to regenerate, repair, or replace damaged tissues and organs using a combination of cells, scaffolds, and bioactive molecules. While the potential benefits of tissue engineering are vast, it also raises significant ethical questions that demand careful consideration.

At its core, tissue engineering holds the promise of transforming healthcare by providing alternatives to traditional organ transplants, which is often limited by donor shortages, immune rejection, and the need for lifelong immunosuppression. With tissue engineering, scientists can create tissues and organs tailored to individual patients (using their own tissue), which reduces the risk of rejection and eliminates the need for donor matching.

One of the most common applications of tissue engineering is in the field of regenerative medicine. Imagine a world where patients with severe burns can have their skin regenerated using bioengineered skin substitutes, or where individuals with a damaged cartilage can receive custom-made cartilage implants! These advancements have the potential to improve countless lives, offering hope to where previously there was none.

Ethical concerns loom over the field of tissue engineering, prompting researchers and policy makers to navigate a complex ethical area. One of the primary concerns is the source of cells used in tissue engineering. While some cells can be harvested from a patient’s own body, others may come from embryonic stem cells or induced pluripotent stem cells (iPSCs), raising ethical questions about the destruction of human embryos and the manipulation of genetic material. Moreover, the commercialisation of tissue engineering raises concerns about accessibility and fairness in healthcare. Will these cutting-edge treatments be available only to the wealthy and elite, widening the gap between those who can have access and those who don’t? Ensuring equal access to tissue-engineered therapies is not just a matter of scientific advancement but also a moral imperative.

Another ethical dilemma arises from the potential for unintended consequences. As we delve deeper into the complexities of tissue engineering, we must be mindful of the long-term effects of manipulating biological systems. Could bioengineered tissues lead to unforeseen health complications down the line? These are questions that require ongoing research.

Despite these ethical challenges, the field of tissue engineering holds tremendous promise for the future of medicine. By cultivating interdisciplinary collaboration and engaging in transparent dialogue with stakeholders, we can navigate the ethical complexities while harnessing the full potential of tissue engineering to alleviate human suffering and improve quality of life.

In conclusion, tissue engineering represents a remarkable collaboration of science, engineering, and medicine, offering unprecedented opportunities to address some of the most pressing health challenges of our time. However, as we journey into this brave new world of regenerative medicine, we must tread carefully, ensuring that our scientific advancements are guided by ethical principles and a commitment to the greater good. Only then can we fully realize the transformative potential of tissue engineering while upholding the rights of all individuals.

Bioprinting- Is this the future?

Bioprinting technology involves bioink and biomaterials that are mixed with cells, used as the printing material for 3D printing. This involves techniques like cell culturing, growth factors, and using the bioink and biomaterials to fabricate biomedical parts to imitate tissue characteristics (involving tissue engineering) and form functional biofilms. Unlike normal 3D printers, bioprinters utilise bioinks are designed to print biological materials specifically.

Inkjet 3D bioprinting is a type of bioprinting technology. Some benefits of this technology is its high speed and availability.

The first 3D printed organ, bladder, was transplanted into a human in 1999.

In 2022, a biotech company, 3DBio Therapeutics, printed an ear implant for a 20-year-old woman. She had her external ear reconstructed using 3D-printed living tissue implant.